N=47 (100%) | |
---|---|
Age (median, range) | 58 (34-77) |
FIGO stage | |
II | 1 (2.1) |
IIIA | 1 (2.1) |
IIIB | 5 (10.6) |
IIIC | 32 (68.2) |
IV | 8 (17.0) |
Residual disease | |
None | 16 (34.0) |
<2cm | 17 (36.2) |
>2cm | 13 (27.7) |
Numbers of chemotherapy cycles | |
<6 | 7 (14.9) |
6 or more | 39 (83.0) |
CSb | 33 (70.2) |
CRb | 14 (29.8) |
6-month recurrent free survival (95%CI)c | 0.53 (0.38-0.66) |
3-year overall survival (95%CI)c | 0.47 (0.29-0.63) |